Moody Aldrich Partners LLC Sells 10,998 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Moody Aldrich Partners LLC decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 19.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 45,897 shares of the company’s stock after selling 10,998 shares during the period. Moody Aldrich Partners LLC owned approximately 0.05% of HealthEquity worth $4,404,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in HQY. Raymond James Trust N.A. grew its stake in HealthEquity by 4.8% in the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after purchasing an additional 132 shares during the period. UMB Bank n.a. raised its position in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after acquiring an additional 164 shares during the period. Truist Financial Corp boosted its stake in HealthEquity by 7.0% in the second quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock valued at $247,000 after acquiring an additional 188 shares during the last quarter. Elk River Wealth Management LLC grew its position in shares of HealthEquity by 0.3% during the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock valued at $5,417,000 after acquiring an additional 217 shares during the period. Finally, Nicolet Advisory Services LLC increased its stake in shares of HealthEquity by 5.8% during the 3rd quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock worth $330,000 after purchasing an additional 233 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now owns 3,784 shares in the company, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the transaction, the director now owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 34,289 shares of company stock valued at $3,355,718. Company insiders own 2.20% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on HQY. Bank of America boosted their price objective on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Barrington Research raised their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. The Goldman Sachs Group started coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 price objective for the company. BTIG Research raised their price target on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Finally, Royal Bank of Canada boosted their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $110.71.

HealthEquity Stock Up 3.2 %

HQY opened at $107.71 on Wednesday. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $107.89. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The business’s 50-day moving average price is $99.74 and its 200-day moving average price is $87.87. The company has a market cap of $9.33 billion, a P/E ratio of 98.82, a P/E/G ratio of 1.86 and a beta of 0.54.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the firm posted $0.40 earnings per share. On average, equities analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.